Metropolitan Life Insurance Company (MetLife)’s Orthofix Medical OFIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,951
| Closed | -$28.3K | – | 1450 |
|
|
2024
Q1 | $28.3K | Hold |
1,951
| – | – | ﹤0.01% | 1691 |
|
|
2023
Q4 | $26.3K | Hold |
1,951
| – | – | ﹤0.01% | 1789 |
|
|
2023
Q3 | $25.1K | Hold |
1,951
| – | – | ﹤0.01% | 1779 |
|
|
2023
Q2 | $35.2K | Hold |
1,951
| – | – | ﹤0.01% | 1638 |
|
|
2023
Q1 | $32.7K | Buy |
1,951
+597
| +44% | +$11.7K | ﹤0.01% | 1622 |
|
|
2022
Q4 | $27.8K | Hold |
1,354
| – | – | ﹤0.01% | 1828 |
|
|
2022
Q3 | $25.9K | Hold |
1,354
| – | – | ﹤0.01% | 1882 |
|
|
2022
Q2 | $31.9K | Hold |
1,354
| – | – | ﹤0.01% | 1783 |
|
|
2022
Q1 | $44.3K | Sell |
1,354
-4,736
| -78% | -$152K | ﹤0.01% | 1668 |
|
|
2021
Q4 | $189K | Hold |
6,090
| – | – | ﹤0.01% | 2068 |
|
|
2021
Q3 | $232K | Hold |
6,090
| – | – | ﹤0.01% | 1956 |
|
|
2021
Q2 | $244K | Buy |
6,090
+298
| +5% | +$12.6K | ﹤0.01% | 2000 |
|
|
2021
Q1 | $251K | Sell |
5,792
-367
| -6% | -$16.2K | ﹤0.01% | 1859 |
|
|
2020
Q4 | $265K | Hold |
6,159
| – | – | ﹤0.01% | 1751 |
|
|
2020
Q3 | $192K | Hold |
6,159
| – | – | ﹤0.01% | 1801 |
|
|
2020
Q2 | $197K | Hold |
6,159
| – | – | ﹤0.01% | 1802 |
|
|
2020
Q1 | $173K | Hold |
6,159
| – | – | ﹤0.01% | 1677 |
|
|
2019
Q4 | $284K | Hold |
6,159
| – | – | ﹤0.01% | 1672 |
|
|
2019
Q3 | $327K | Hold |
6,159
| – | – | 0.01% | 1554 |
|
|
2019
Q2 | $326K | Hold |
6,159
| – | – | 0.01% | 1566 |
|
|
2019
Q1 | $347K | Hold |
6,159
| – | – | 0.01% | 1534 |
|
|
2018
Q4 | $323K | Hold |
6,159
| – | – | 0.01% | 1502 |
|
|
2018
Q3 | $356K | Hold |
6,159
| – | – | 0.01% | 1613 |
|
|
2018
Q2 | $350K | Buy |
6,159
+289
| +5% | +$16.5K | 0.01% | 1556 |
|
|
2018
Q1 | $345K | Buy |
5,870
+38
| +0.7% | +$2.13K | ﹤0.01% | 1516 |
|
|
2017
Q4 | $319K | Sell |
5,832
-5,678
| -49% | -$294K | ﹤0.01% | 1579 |
|
|
2017
Q3 | $544K | Sell |
11,510
-2,037
| -15% | -$95.9K | ﹤0.01% | 1643 |
|
|
2017
Q2 | $630K | Hold |
13,547
| – | – | ﹤0.01% | 1525 |
|
|
2017
Q1 | $517K | Hold |
13,547
| – | – | ﹤0.01% | 1630 |
|
|
2016
Q4 | $490K | Hold |
13,547
| – | – | ﹤0.01% | 1744 |
|
|
2016
Q3 | $579K | Sell |
13,547
-645
| -5% | -$28.8K | ﹤0.01% | 1614 |
|
|
2016
Q2 | $602K | Buy |
+14,192
| New | +$617K | ﹤0.01% | 1567 |
|
|
2014
Q3 | – | Sell |
-15,134
| Closed | -$456K | – | 2707 |
|
|
2014
Q2 | $456K | Hold |
15,134
| – | – | ﹤0.01% | 1899 |
|
|
2014
Q1 | $456K | Sell |
15,134
-321
| -2% | -$7.4K | ﹤0.01% | 1871 |
|
|
2013
Q4 | $353K | Hold |
15,455
| – | – | ﹤0.01% | 2057 |
|
|
2013
Q3 | $322K | Hold |
15,455
| – | – | ﹤0.01% | 2054 |
|
|
2013
Q2 | $416K | Buy |
+15,455
| New | +$463K | ﹤0.01% | 1813 |
|
Other funds holding OFIX
AC
RCMNY
ECM
PCMI
NM
GCM
Metropolitan Life Insurance Company (MetLife)'s OFIX Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Orthofix Medical (OFIX) in Q2 2024, closing a stake of 1,951 shares — an estimated $28.3K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in OFIX in Q2 2013 and held it in 37 quarters. The position peaked at $630K in Q2 2017. 130 funds tracked by Wall St. Rank hold OFIX as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Orthofix Medical position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 1,951 Orthofix Medical shares in Q2 2024, an estimated $28.3K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Orthofix Medical in Q2 2013 and held it in 37 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Orthofix Medical position peaked at $630K in Q2 2017.
- 130 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.